kabutan

Linical Co., Ltd.(2183) Summary

2183
TSE Standard
Linical Co., Ltd.
310
JPY
0
(0.00%)
Jan 29, 3:30 pm JST
2.02
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
308.9
Jan 29, 2:45 pm JST
Summary Chart Historical News Financial Result
PER
PBR
1.16
Yield
5.16%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
315 JPY 2.05 USD
Previous Close Jan 28
310 JPY 2.03 USD
High Jan 29, 9:00 am
315 JPY 2.05 USD
Low Jan 29, 9:50 am
306 JPY 1.99 USD
Volume
35,800
Trading Value
0.01B JPY 0.07M USD
VWAP
308.12 JPY 2.01 USD
Minimum Trading Value
31,000 JPY 202 USD
Market Cap
7.67B JPY 0.05B USD
Number of Trades
84
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
55
1-Year High Jan 30, 2025
296
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 0 210,800
Jan 16, 2026 0 210,800
Jan 9, 2026 0 151,900
Dec 26, 2025 0 140,900
Dec 19, 2025 0 139,600
Company Profile
Linical Co., Ltd. specializes in contract research for pharmaceutical development, focusing on Phase II and III clinical trials. The company also provides support for pharmaceutical sales.
Sector
Services
Linical Co., Ltd. primarily engages in Contract Research Organization (CRO) services for pharmaceutical development, while also offering post-marketing support services for pharmaceuticals. In its CRO business, the company undertakes various tasks including clinical trial monitoring, quality control, data management, statistical analysis, and medical writing for documents such as clinical trial protocols. Additionally, Linical provides drug discovery support services, offering consulting on development strategy planning, regulatory affairs, and approval applications for biotech venture companies. In its post-marketing support business, Linical handles planning, monitoring, and auditing services. Through these operations, Linical offers comprehensive global services spanning from drug discovery support to clinical development, and post-approval lifecycle management, including post-marketing clinical trials and research.